These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 4155663)
21. [Treatment of Parkinsonism with Tremarial (SJ-1977)]. Kondo K; Takahashi Y; Yamamoto T; Matsumura K; Okuda Y No To Shinkei; 1967 Jul; 19(7):723-7. PubMed ID: 4384268 [No Abstract] [Full Text] [Related]
22. Treatment of extrapyramidal side effects with terguride. Filip V; Marsálek M; Hálková E; Karen P Psychiatry Res; 1992 Jan; 41(1):9-16. PubMed ID: 1348584 [TBL] [Abstract][Full Text] [Related]
23. [Pipothiazine (piportil) in the treatment of various forms of schizophrenia]. Matkowski K; Sep-Kowalikowa B Psychiatr Pol; 1979; 13(4):421-3. PubMed ID: 42095 [No Abstract] [Full Text] [Related]
29. Agranulocytosis in the course of phenothiazine therapy: case reports. Yassa R J Clin Psychiatry; 1985 Aug; 46(8):341-3. PubMed ID: 2862136 [TBL] [Abstract][Full Text] [Related]
30. Amelioration of drug-induced Parkinsonism by ECT. Ananth J; Samra D; Kolivakis T Am J Psychiatry; 1979 Aug; 136(8):1094. PubMed ID: 37749 [No Abstract] [Full Text] [Related]
31. Increased manganese-superoxide dismutase activity in postmortem brain from neuroleptic-treated psychotic patients. Loven DP; James JF; Biggs L; Little KY Biol Psychiatry; 1996 Aug; 40(3):230-2. PubMed ID: 8830959 [No Abstract] [Full Text] [Related]
32. Ethosuximide and tremor in Parkinson's disease: a pilot study. Pourcher E; Gomez-Mancilla B; Bédard PJ Mov Disord; 1992; 7(2):132-6. PubMed ID: 1350060 [TBL] [Abstract][Full Text] [Related]
33. Thrombocytopenia possibly associated with olanzapine and subsequently with benztropine mesylate. Bogunovic O; Viswanathan R Psychosomatics; 2000; 41(3):277-8. PubMed ID: 10849461 [No Abstract] [Full Text] [Related]
34. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses. Salvesen C; Vaksdal K Behav Neuropsychiatry; 1973 Oct-1974 Mar; 5(7-12):3-7. PubMed ID: 4154740 [No Abstract] [Full Text] [Related]
35. [Clinical experience with fluphenazine decanoate in psychoses]. Náhunek K; Rodová A; Svestka J Act Nerv Super (Praha); 1970 Jan; 12(1):47-9. PubMed ID: 5460564 [No Abstract] [Full Text] [Related]
36. Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa. Hardie RJ; Lees AJ J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):850-4. PubMed ID: 2900293 [TBL] [Abstract][Full Text] [Related]
37. Pilot trials with long-acting pipotiazine injections. Hakola A Acta Psychiatr Scand Suppl; 1973; 241():31-42. PubMed ID: 4147509 [No Abstract] [Full Text] [Related]
38. Antipsychotic medication and the elderly. Raskin DE J Clin Psychiatry; 1985 May; 46(5 Pt 2):36-40. PubMed ID: 2859280 [TBL] [Abstract][Full Text] [Related]
39. Differentiating Parkinson's disease from drug-induced Parkinsonism. Wearne D; McCarthy M; Orr C Aust N Z J Psychiatry; 2019 Sep; 53(9):923-924. PubMed ID: 30897918 [No Abstract] [Full Text] [Related]
40. Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome. Schaefer W Int J Urol; 2007 Jul; 14(7):670; author reply 670-1. PubMed ID: 17645621 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]